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New mRNA modification?
L
ike the rough draft of a novel, a newly transcribed pre-mRNA 
molecule undergoes plenty of polishing before it’s fi  t to be read. 
Custódio et al. now report evidence for a previously undiscovered 
editing step in the production of mRNA.
Cells are fussy about mRNA. They detain a would-be strand in the 
nucleus until enzymes cleave the 3′ end, excise introns, stick a cap on the 
5′ end, and affi  x a tail of multiple adenines. The carboxyl end of RNA 
polymerase II, the enzyme that transcribes RNA, orchestrates processing 
by latching onto editorial proteins. This end normally carries 52 copies of 
a 7-amino acid sequence. By deleting different combinations of these 
duplications, researchers previously determined that certain repeats 
attract proteins that perform specifi  c mRNA alterations.
Custódio et al. engineered mouse cells to make RNA polymerase 
molecules with untested combinations of deletions. The protein carrying 
fi  ve repeats was nonfunctional. But the one with 31 repeats could transcribe 
a human β-globin gene and complete the four processing steps. Nevertheless, 
the RNA strand remained stuck at the transcription site. Its retention suggests 
that the pre-mRNA must pass through an as-yet undefi  ned editing round 
before the cell will release it into the cytoplasm.
RNA polymerase presumably draws in proteins that perform this new altera-
tion. The researchers hope to pin down these proteins by comparing the binding 
partners of RNA polymerases with truncated and full-length carboxyl ends. Once 
the team knows the proteins’ identities, they can work out their functions. 
Reference: Custódio, N., et al. 2007. J. Cell Biol. 179:199–207.
RNA polymerase on 
the clock
I
s RNA polymerase II slacking off while it’s 
supposed to be on the job? Probably not. But 
as Boireau et al. report, the ﬁ  rst  measure-
ments of RNA kinetics in individual cells show 
an unaccounted for two and a half minutes in 
the protein’s schedule.
Using groups of cells, researchers have 
previously determined averages for how many 
nucleotides RNA polymerase II can add in a min-
ute (900–1,800), its initiation rate, and other 
variables. To reﬁ  ne these ﬁ  gures, Boireau et al. 
gauged how fast single cells transcribe a seg-
ment of the HIV genome. The researchers altered 
the segment to contain multiple binding sites for 
the protein MS2. By adding GFP-labeled MS2, 
which binds to the transcript, the researchers 
could track the growth of the new RNA strand. 
Mathematical models then allowed the team to 
calculate the timing of different steps.
RNA polymerase II added more than 1,800 
bases/min—above the average gleaned from in 
vitro studies, suggesting that an HIV protein might 
boost its speed. The polymerase spent just over 
ﬁ  ve and a half minutes at the transcription site. 
Of this time, making the RNA strand took 114 
seconds, and processing the 3′ end and other 
housekeeping tasks required another 63 sec-
onds. That left 156 seconds unexplained.
What the protein does during this gap is 
unclear. The extra time might indicate that the 
protein pauses on the promoter before it starts 
transcribing or that it performs some other un-
discovered function. The next step, the re-
searchers say, is making the same measure-
ments for cellular genes. 
Reference: Boireau, S., et al. 2007. J. Cell Biol. 
179:291–304.
Filopodia motor ahead
T
he motor protein MyoX is more than a cellular U-Haul, as Tokuo et al. 
now show. The protein also helps a cell crawl by muscling actin 
ﬁ  laments into position at the front edge of the membrane.
As a cell slithers, it sends out skinny extensions called ﬁ  lopodia that 
help guide its movements. Previous work has shown that the cargo-hauling 
protein MyoX spurs formation of these structures. The molecule’s head 
grips and slides along actin ﬁ  laments, while its tail holds cargo. MyoX 
travels to the tips of ﬁ  lopodia, and researchers assumed that the cargos it 
takes there stimulate the extensions to sprout and grow.
That explanation was only half right, as Tokuo et al. found when 
they tested tailless MyoX molecules that can’t ferry anything. Dimers of 
the trimmed molecules still triggered ﬁ  lopodia, but the extensions were 
stumpy and short lived. Bundles of actin ﬁ  laments normally line up along 
the leading edge of a crawling cell. This orderly arrangement vanished 
when MyoX was eliminated using RNAi.
The results indicate that MyoX has two 
jobs during ﬁ  lopodium formation. First, the 
motor portion bunches up actin ﬁ  laments at the 
base of the incipient ﬁ  lopodium, prompting it 
to bulge out. Then MyoX can slide along the 
actin ﬁ  bers into the protrusion, where it depos-
its its cargos that cause further elongation. The 
team now wants to determine how MyoX gets 
to the cell’s leading edge and how it wrenches 
the actin ﬁ  laments into place. 
Reference: Tokuo, H., et al. 2007. J. Cell Biol. 
179:229–238.
A glow marking an HIV transcription site allows 
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